Dr. Ram Yogendra

They will go and they will interview Bruce and I, get a little quote, and then they'll go to the expert who will then try to discredit us.

They will go and they will interview Bruce and I, get a little quote, and then they'll go to the expert who will then try to discredit us.

And it turns out most of the experts and these people that crapped on us all had conflicts of interest, whether they were paid by pharma, which if you go to openpayments.gov, you can look and see who's been paid by pharma, or they have some sort of competing interests between a lab or some research that they're trying to do.

And it turns out most of the experts and these people that crapped on us all had conflicts of interest, whether they were paid by pharma, which if you go to openpayments.gov, you can look and see who's been paid by pharma, or they have some sort of competing interests between a lab or some research that they're trying to do.

Yeah, so we've actually got, so we're doing a, the FDA has approved a clinical trial with long COVID, which is studying the spike proteins and the vascular monocytes from the COVID infection. We actually have congressional support.

Yeah, so we've actually got, so we're doing a, the FDA has approved a clinical trial with long COVID, which is studying the spike proteins and the vascular monocytes from the COVID infection. We actually have congressional support.

Well, we're going to do both. So right now, what we're working on is Senator Todd Young has really been a big supporter of us, and he's helping us with Congressman Pete Stauber in Minnesota and Congressman Jeff Crank in Colorado.

Well, we're going to do both. So right now, what we're working on is Senator Todd Young has really been a big supporter of us, and he's helping us with Congressman Pete Stauber in Minnesota and Congressman Jeff Crank in Colorado.

who are just running up and down the halls of uh in dc uh trying to help us right now which is uh which is incredible and i know a lot of people saw uh senator young uh with the rfk confirmation and he's been really a big uh advocate for the the long covet community and which was a testament because one of the things i want to mention is that you know this whole there's a whole division an argument about long covet and long backs and it's

who are just running up and down the halls of uh in dc uh trying to help us right now which is uh which is incredible and i know a lot of people saw uh senator young uh with the rfk confirmation and he's been really a big uh advocate for the the long covet community and which was a testament because one of the things i want to mention is that you know this whole there's a whole division an argument about long covet and long backs and it's

Sort of a right wing versus left. And we've got a lot of support from from the GOP side. And I keep telling people this long COVID is not a left wing liberal disease. You know, this is this is something. You're right, this is something actually GOP, we've got more congressional Republican senators and congressmen behind us than unfortunately our Democrat side and shouldn't be political.

Sort of a right wing versus left. And we've got a lot of support from from the GOP side. And I keep telling people this long COVID is not a left wing liberal disease. You know, this is this is something. You're right, this is something actually GOP, we've got more congressional Republican senators and congressmen behind us than unfortunately our Democrat side and shouldn't be political.

So we got an FDA approved clinical study that we're trying to get funding to and hopefully we should have, we've got a couple of leads that Senator Young is working on. Now that this paper- This is for treatment?

So we got an FDA approved clinical study that we're trying to get funding to and hopefully we should have, we've got a couple of leads that Senator Young is working on. Now that this paper- This is for treatment?

Yeah, it's a morale bracket. Marabara, ketorvastatin, phase three FDA approved clinical trial that in 16 weeks if the trial is successful, we'll have the first approved medication for long COVID. And what I've done, I've actually just finished writing the protocol now that our vaccine paper is published, is a phase three clinical trial for post COVID vaccine syndrome.

Yeah, it's a morale bracket. Marabara, ketorvastatin, phase three FDA approved clinical trial that in 16 weeks if the trial is successful, we'll have the first approved medication for long COVID. And what I've done, I've actually just finished writing the protocol now that our vaccine paper is published, is a phase three clinical trial for post COVID vaccine syndrome.

which we're submitting to the FDA in about a week, and then hopefully get funding to run. Is that a different protocol? It's a different protocol. Yep, that's a different protocol we're going to submit to the FDA.

which we're submitting to the FDA in about a week, and then hopefully get funding to run. Is that a different protocol? It's a different protocol. Yep, that's a different protocol we're going to submit to the FDA.

Yeah, again, it's the same thing. It's a Mirovac and a statin combination, but the patient population is going to be different. We're going to look at vaccine-injured patients and then screen them one year not having a COVID infection. You know, here's the thing, Drew, that's difficult about studying the vaccine group right now because many of them got COVID afterwards, so it sort of muddies up.

Yeah, again, it's the same thing. It's a Mirovac and a statin combination, but the patient population is going to be different. We're going to look at vaccine-injured patients and then screen them one year not having a COVID infection. You know, here's the thing, Drew, that's difficult about studying the vaccine group right now because many of them got COVID afterwards, so it sort of muddies up.